BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24563226)

  • 1. Hippocampal glycogen synthase kinase 3β is critical for the antidepressant effect of cyclin-dependent kinase 5 inhibitor in rats.
    Li G; Liu T; Kong X; Wang L; Jin X
    J Mol Neurosci; 2014 Sep; 54(1):92-9. PubMed ID: 24563226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats.
    Zhu WL; Wang SJ; Liu MM; Shi HS; Zhang RX; Liu JF; Ding ZB; Lu L
    J Psychiatry Neurosci; 2013 Sep; 38(5):306-16. PubMed ID: 23611177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roscovitine, a CDK5 Inhibitor, Alleviates Sevoflurane-Induced Cognitive Dysfunction via Regulation Tau/GSK3β and ERK/PPARγ/CREB Signaling.
    Liu J; Yang J; Xu Y; Guo G; Cai L; Wu H; Zhao Y; Zhang X
    Cell Physiol Biochem; 2017; 44(2):423-435. PubMed ID: 29141245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
    Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
    J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of CRMP2 by Cdk5 and GSK-3β participates in sevoflurane-induced dendritic development abnormalities and cognitive dysfunction in developing rats.
    Liao Z; Huang Z; Li J; Li H; Miao L; Liu Y; Zhang J; Xu Y; Li Y
    Toxicol Lett; 2021 May; 341():68-79. PubMed ID: 33548343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Cdk5/p35 activity in the dentate gyrus mediates depressive-like behaviour in rats.
    Zhu WL; Shi HS; Wang SJ; Xu CM; Jiang WG; Wang X; Wu P; Li QQ; Ding ZB; Lu L
    Int J Neuropsychopharmacol; 2012 Jul; 15(6):795-809. PubMed ID: 21682945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats.
    Parkitna JR; Obara I; Wawrzczak-Bargiela A; Makuch W; Przewlocka B; Przewlocki R
    J Pharmacol Exp Ther; 2006 Nov; 319(2):832-9. PubMed ID: 16902054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.
    Price DA; Sorkin A; Zahniser NR
    Mol Pharmacol; 2009 Oct; 76(4):812-23. PubMed ID: 19628755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
    Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
    Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent roles of GSK3 and CDK5 in APP processing.
    Ryder J; Su Y; Liu F; Li B; Zhou Y; Ni B
    Biochem Biophys Res Commun; 2003 Dec; 312(4):922-9. PubMed ID: 14651959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK3β inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neurons.
    de la Torre AV; Junyent F; Folch J; Pelegrí C; Vilaplana J; Auladell C; Beas-Zarate C; Pallàs M; Verdaguer E; Camins A
    Pharmacol Res; 2012 Jan; 65(1):66-73. PubMed ID: 21875668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BDNF/TrkB signaling pathway is involved in heat hyperalgesia mediated by Cdk5 in rats.
    Zhang HH; Zhang XQ; Xue QS; Yan-Luo ; Huang JL; Zhang S; Shao HJ; Lu H; Wang WY; Yu BW
    PLoS One; 2014; 9(1):e85536. PubMed ID: 24465591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA neuroprotection against a phosphatidylinositol-3 kinase inhibitor, LY294002 by NR2B-mediated suppression of glycogen synthase kinase-3beta-induced apoptosis.
    Habas A; Kharebava G; Szatmari E; Hetman M
    J Neurochem; 2006 Jan; 96(2):335-48. PubMed ID: 16300633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdk5 inhibitor roscovitine alleviates neuropathic pain in the dorsal root ganglia by downregulating N-methyl-D-aspartate receptor subunit 2A.
    Yang L; Gu X; Zhang W; Zhang J; Ma Z
    Neurol Sci; 2014 Sep; 35(9):1365-71. PubMed ID: 24659417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol exerts a protective effect in chronic unpredictable mild stress-induced depressive-like behavior: involvement of the AKT/GSK3β signaling pathway in hippocampus.
    Shen J; Qu C; Xu L; Sun H; Zhang J
    Psychopharmacology (Berl); 2019 Feb; 236(2):591-602. PubMed ID: 30374891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of extensive neurofilament phosphorylation rescues α-Internexin/peripherin-overexpressing PC12 cells from neuronal cell death.
    Lee WC; Kan D; Chen YY; Han SK; Lu KS; Chien CL
    PLoS One; 2012; 7(8):e43883. PubMed ID: 22952800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of citalopram on chronic stress-induced depressive-like behavior in rats through GSK3β/β-catenin activation in the medial prefrontal cortex.
    Chen YC; Tan QR; Dang W; Wang HN; Zhang RB; Li ZY; Lin H; Liu R
    Brain Res Bull; 2012 Jul; 88(4):338-44. PubMed ID: 22472057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13.
    Lu Y; Wang C; Xue Z; Li C; Zhang J; Zhao X; Liu A; Wang Q; Zhou W
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25542689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine up-regulates a cluster of intronic miRNAs within the serotonin receptor 2C gene by inhibiting glycogen synthase kinase-3.
    Grieco SF; Velmeshev D; Magistri M; Eldar-Finkelman H; Faghihi MA; Jope RS; Beurel E
    World J Biol Psychiatry; 2017 Sep; 18(6):445-456. PubMed ID: 27723376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.